E70.0 Classical phenylketonuria

Name of the Condition

• Classical phenylketonuria (ICD-10 Code: E70.0)

Summary

Classical phenylketonuria is a rare genetic disorder that impairs the body's ability to process the amino acid phenylalanine. This leads to its accumulation in the blood and brain, causing neurological damage if untreated. Early detection and dietary management are essential to prevent severe complications.

Causes

Classical phenylketonuria is caused by mutations in the PAH gene, which encodes the enzyme phenylalanine hydroxylase. These mutations reduce or eliminate the enzyme's activity, preventing the breakdown of phenylalanine into tyrosine. The condition follows an autosomal recessive inheritance pattern.

Risk Factors

• Genetic predisposition; family history of phenylketonuria.
• Consanguinity (parents who are close relatives).
• Certain ethnic groups with higher carrier rates for PAH gene mutations.

Symptoms

• Neurological issues, such as developmental delay, intellectual disability, or seizures.
• Behavioral changes, including irritability or hyperactivity.
• Physical symptoms like eczema or musty body odor.
• Light skin and hair pigmentation due to reduced melanin production.

Diagnosis

Diagnosis typically involves newborn screening for elevated phenylalanine levels. Confirmatory testing includes genetic analysis of the PAH gene and measurement of phenylalanine hydroxylase activity. Early detection through screening programs is critical.

Treatment Options

• Lifelong dietary restriction of phenylalanine, primarily from protein sources.
• Specialized medical formulas and low-protein foods to meet nutritional needs.
• Regular monitoring of blood phenylalanine levels to adjust dietary intake.
• Adjunct therapies for associated symptoms, such as seizures or behavioral issues.

Prognosis and Follow-Up

With strict dietary management, individuals can lead healthy lives and avoid severe neurological damage. Regular follow-up with metabolic specialists is necessary to monitor growth, development, and dietary adherence. Outcomes depend on the timeliness and consistency of treatment.

Complications

• Untreated, severe intellectual disability and developmental delays.
• Neurological complications, including seizures or movement disorders.
• Behavioral issues, such as anxiety or attention deficits.
• Growth retardation and nutritional deficiencies if dietary management is inadequate.

Lifestyle & Prevention

• Adherence to a phenylalanine-restricted diet under medical supervision.
• Avoidance of high-protein foods like meat, dairy, and certain grains.
• Use of specialized medical formulas to ensure adequate nutrition.
• Genetic counseling for families with a history of the condition.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as seizures, severe developmental regression, or unexplained irritability occur. Regular follow-up with a metabolic specialist is recommended for ongoing management and monitoring.

Tips for Medical Coders

• Use E70.0 for classical phenylketonuria, ensuring documentation supports the diagnosis (e.g., genetic testing, elevated phenylalanine levels).
• Differentiate from other phenylketonuria variants (e.g., variant or malignant) by verifying clinical and laboratory findings.
• Confirm the absence of modifiers or additional codes unless specified by documentation (e.g., complications or associated conditions).